The association with IDH-mutant gliomas was persistently significant, when analyzed for different WHO-grades or for different genetic subtypes (carrying mutational profiles attributed to oligodendrogliomas or astrocytomas by the 2014 Haarlem Consensus)23. Here, IDH1 is linked to central nervous system cancer.